160 related articles for article (PubMed ID: 1233337)
21. [Disorders of fibrinogen metabolism in thoracic and abdominal injuries].
Chalenko VV
Klin Med (Mosk); 1990 May; 68(5):121-4. PubMed ID: 2398710
[No Abstract] [Full Text] [Related]
22. [Effects of different types of substitutive treatment on fibrinolytic potential of chronic uremic patients].
Canavese C; Stratta P; Mangiarotti G; Triolo G; Bagnis C; Racca M; Vercellone A
Minerva Nefrol; 1981; 28(3):339-43. PubMed ID: 7329613
[No Abstract] [Full Text] [Related]
23. Metabolism of fibrinogen in cirrhosis of the liver.
Tytgat GN; Collen D; Verstraete M
South Med J; 1971 Oct; 64(10):1690-701. PubMed ID: 5125556
[No Abstract] [Full Text] [Related]
24. [Aspects of water-electrolyte metabolism studied with muscle needle-biopsy. Findings in cardiac insufficiency, hepatic cirrhosis, diabetes mellitus and chronic renal insufficiency].
Ossi E; Mioni G; D'Angelo A; Lupo A; Valvo E; Maschio G
G Clin Med; 1974 Feb; 55(2):131-44. PubMed ID: 4419276
[No Abstract] [Full Text] [Related]
25. The binding of 125I-fibrinogen to blood platelets in patients with chronic uraemia.
Komarnicki M; Zozulińska M; Zawilska K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):638-41. PubMed ID: 2448203
[TBL] [Abstract][Full Text] [Related]
26. Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
Thekkedath UR; Chirananthavat T; Leypoldt JK; Cheung AK; Mohammad SF
Am J Hematol; 2006 Dec; 81(12):915-26. PubMed ID: 16917914
[TBL] [Abstract][Full Text] [Related]
27. Glucose, insulin and glucagon response to intravenous glucose load in patients on chronic hemodialysis.
Shasha SM; Nusem D; Kanter Y; Weiner F
Isr J Med Sci; 1988 Jan; 24(1):15-9. PubMed ID: 3279011
[TBL] [Abstract][Full Text] [Related]
28. [Parathyroid adenoma (tertiary hyperparathyroidosis) in uremic patients treated by chronic hemodialysis].
Szúcs J; Molnár E; Hamvas A
Orv Hetil; 1978 Jan; 119(3):155-8. PubMed ID: 622269
[No Abstract] [Full Text] [Related]
29. Erythrocyte transketolase activity in dialyzed patients. A reversible metabolic lesion of uremia.
Lonergan ET; Semar M; Sterzel RB; Treser G; Needle MA; Voyles L; Lange K
N Engl J Med; 1971 Jun; 284(25):1399-403. PubMed ID: 4325316
[No Abstract] [Full Text] [Related]
30. Chronic intravascular coagulation. Clinical spectrum and diagnostic criteria, with special emphasis on metabolism, distribution and localization of I 131 -fibrinogen.
Straub PW
Acta Med Scand Suppl; 1971; 526():1-95. PubMed ID: 5292077
[No Abstract] [Full Text] [Related]
31. High prevalence of lupus anticoagulant in hemodialysis patients.
Quereda C; Pardo A; Lamas S; Marcén R; García-Avello A; Orofino L; Navarro JL; Ortuño J
Life Support Syst; 1985; 3 Suppl 1():58-62. PubMed ID: 3939677
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of several parameters of coagulation in liver cirrhosis: disseminated intravascular coagulation or pseudo-disseminated intravascular coagulation?].
Petrella V; Parachini F; Rigotti T; Galimberti M; Cusumano S
Minerva Med; 1988 Mar; 79(3):193-8. PubMed ID: 3362400
[TBL] [Abstract][Full Text] [Related]
33. [Disorders of blood coagulation and fibrinolysis in patients with chronic renal failure during treatment with hemodialysis, and methods of correction].
Neĭmark MI
Ter Arkh; 1984; 56(7):48-53. PubMed ID: 6484834
[No Abstract] [Full Text] [Related]
34. [Study of the blood platelets in chronic dialyzed patients before and after hemodialysis. Comparison with a group of patients with grave chronic uremia treated with occasional dialysis].
Praga C; Brancaccio D; Pogliani E; Della Grazia M
Minerva Nefrol; 1968; 15(5):322-6. PubMed ID: 5743459
[No Abstract] [Full Text] [Related]
35. Glucose titration studies in patients with chronic progressive renal disease.
Rieselbach RE; Shankel SW; Slatopolsky E; Lubowitz H; Bricker NS
J Clin Invest; 1967 Feb; 46(2):157-63. PubMed ID: 6018755
[TBL] [Abstract][Full Text] [Related]
36. [Physiopathological and hemodialytic problems in chronic uremia after bilateral nephrectomy].
Bonomini V; Mioli V; Vangelista A; Albertazzi A; Martelli A; Platania A; Reggiani A; Rusconi R
Minerva Nefrol; 1969; 16(6):391-4. PubMed ID: 4934097
[No Abstract] [Full Text] [Related]
37. [Aspects of protein metabolism in chronic uremia. Study completed with the help of nitrogen balance during a course of periodic hemodialysis].
Fiaschi E; Campanacci L; Maschio G; D'Angelo A; Bonadonna A; Ossi E
Minerva Nefrol; 1972; 19(2):70-82. PubMed ID: 4681263
[No Abstract] [Full Text] [Related]
38. [Transfusion-immunization in uremic patients treated by chronic dialysis].
Kaiser G; Gál G; Mészáros E
Orv Hetil; 1975 Mar; 116(11):604-7. PubMed ID: 804152
[No Abstract] [Full Text] [Related]
39. [Incidence of chronic renal failure during 35 years at the Rijeka Clinical Hospital Center].
Orlić L; Matić-Glazar D; Vlahović A; Zivcić-Cosić S; Maleta I; Martinović BS; Racki S; Madzar Z
Acta Med Croatica; 2004; 58(1):73-7. PubMed ID: 15125398
[TBL] [Abstract][Full Text] [Related]
40. [St. Erik Hospital's new unit for dialysis of patients with chronic uremia].
Bergström J; Bergquist-Poppen M; Bucht H
Nord Med; 1969 May; 81(19):585-91. PubMed ID: 4977459
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
